Congratulations to our new member Centre for Innovative Medicine!

We want to congratulate a new member of LBTA: Centre for Innovative Medicine, who’s membership was approved on the 7 December after the board voting. Centre for Innovative Medicine is a State funded Research Institute where important long-term visions of therapeutic and diagnostic strategies are being implemented and translated from fundamental science into clinically relevant knowledge…

LBTA – is a new member of the Bio-based Industries Consortium (BIC)

In order to actively participate in the development of Lithuanian bioindustry and bioeconomy, Lithuanian biotechnology association decided to join the Bio-based Industries Consortium (BIC). BIC – is a Brussels-based European Bioindustry Consortium, which acts as a private partner in the public and private sector together with the EU’s Bio-based Industries Joint Undertaking (BBI JU). More…

European Digital Innovation Hub (EDIH) for the Vilnius region was nominated for European Commission

The Lithuanian Science and Business Consortium has been nominated for the European Commission as the European Digital Innovation Hub (EDIH) for the Vilnius region! EDIH will provide digitisation and innovation support and advisory services to small and medium-sized enterprises and the public sector by pooling the competences and infrastructure of digital technologies. The European Digital…

The WOMEN IN BIOTECH platform launched during the first cycle of events

Four is that is the number of times American and Lithuanian female biotechnology leaders were greeted by the WOMEN IN BIOTECH audience. The speakers introduced four areas of interest during the virtual events: the biotechnology industry, non-governmental organisations, investing and start-up development. The four remote events attracted a total of nearly 1800 participants. Discussions joined…

LBTA entered collaboration agreement with Bio4Dreams

Lithuanian Biotechnology Association and Bio4Dreams, private Life Science incubator based in Italy, have entered into a collaboration framework agreement to identify, accelerate, support, develop and finance promising projects and startups in the Life Sciences. Specifically, as part of the agreement, through periodic physical or virtual meetings, the parties will engage in the activities of: Evaluation of…